• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受激素治疗的前列腺癌患者的身体意象:使用横断面和纵向设计的观察性研究。

Body image in patients with prostate cancer undergoing treatment with hormone therapy: Observational study using both a cross-sectional and longitudinal design.

机构信息

National Taipei University of Nursing and Health Sciences, Taiwan.

Ditmanson Medical Foundation Chia-Yi Christian Hospital, Taiwan.

出版信息

J Health Psychol. 2024 Aug;29(9):921-934. doi: 10.1177/13591053231223930. Epub 2024 Jan 9.

DOI:10.1177/13591053231223930
PMID:38196159
Abstract

This study aims to examine changes in body image (BI) over time and factors related to BI among patients with prostate cancer who receive hormone therapy (HT). A cross-sectional design and longitudinal design were utilized. Patients with prostate cancer who received HT were recruited from the urology outpatient departments in two hospitals in Taiwan between August 2017 and December 2020. Cross-sectional data were collected from 177 patients who had started HT for prostate cancer. Longitudinal data were collected from 34 newly diagnosed patients before receiving HT and at 1, 3, 6, and 12 months after HT. The variables measured included hormonal symptoms and distress, self-efficacy, and BI. The results showed that BI dissatisfaction ranged from 6.1% to 17.2%. Hormonal symptoms and distress (e.g. lack of vitality) were correlated with BI dissatisfaction. Education on the side effects of HT and coping strategies can be provided to patients to prevent BI dissatisfaction.

摘要

本研究旨在探讨接受激素治疗(HT)的前列腺癌患者的体像(BI)随时间的变化以及与 BI 相关的因素。采用了横断面设计和纵向设计。2017 年 8 月至 2020 年 12 月,从台湾两家医院的泌尿科门诊招募了接受 HT 的前列腺癌患者。横断面数据来自 177 名开始接受 HT 的前列腺癌患者。纵向数据来自 34 名新诊断为前列腺癌且在接受 HT 前以及 HT 后 1、3、6 和 12 个月时收集。测量的变量包括激素症状和困扰、自我效能和 BI。结果显示,BI 不满意的比例为 6.1%至 17.2%。激素症状和困扰(如缺乏活力)与 BI 不满意相关。可以向患者提供关于 HT 副作用和应对策略的教育,以预防 BI 不满意。

相似文献

1
Body image in patients with prostate cancer undergoing treatment with hormone therapy: Observational study using both a cross-sectional and longitudinal design.接受激素治疗的前列腺癌患者的身体意象:使用横断面和纵向设计的观察性研究。
J Health Psychol. 2024 Aug;29(9):921-934. doi: 10.1177/13591053231223930. Epub 2024 Jan 9.
2
Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are not.接受激素治疗的前列腺癌患者与未接受激素治疗的前列腺癌患者在重度抑郁症和广泛性焦虑症症状方面的差异。
Psychooncology. 2014 Dec;23(12):1350-5. doi: 10.1002/pon.3566. Epub 2014 Apr 30.
3
Health-related quality of life of exposed versus non-exposed androgen deprivation therapy patients with prostate cancer: a cross-sectional study.雄激素剥夺治疗的前列腺癌暴露与非暴露患者的健康相关生活质量:一项横断面研究。
Int J Clin Pharm. 2019 Aug;41(4):993-1003. doi: 10.1007/s11096-019-00854-y. Epub 2019 Jun 25.
4
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.中高危前列腺癌患者行调强放疗联合与不联合激素治疗的健康相关生活质量的前瞻性分析。
Urol Oncol. 2020 Oct;38(10):794.e1-794.e9. doi: 10.1016/j.urolonc.2020.02.007. Epub 2020 Mar 3.
5
Body image perceptions in men with prostate cancer.前列腺癌男性的身体形象认知
Oncol Nurs Forum. 2009 Mar;36(2):167-72. doi: 10.1188/09.ONF.167-172.
6
Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.晚期前列腺癌患者的生活质量:一项随机治疗试验的结果
J Natl Cancer Inst. 1998 Oct 21;90(20):1537-44. doi: 10.1093/jnci/90.20.1537.
7
A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in Europe.一项评估欧洲患者前列腺癌治疗偏好和经历的非干预性横断面研究。
Adv Ther. 2025 May;42(5):2314-2334. doi: 10.1007/s12325-025-03152-4. Epub 2025 Mar 19.
8
Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.从接受促性腺激素释放激素类似物治疗的前列腺癌患者角度看泌尿科医生和护士的角色
BJU Int. 2008 Nov;102(10):1419-24. doi: 10.1111/j.1464-410X.2008.07785.x. Epub 2008 Jun 11.
9
Patients' perceptions and attitudes on recurrent prostate cancer and hormone therapy: Qualitative comparison between decision-aid and control groups.患者对复发性前列腺癌和激素治疗的认知与态度:决策辅助组与对照组的定性比较
J Geriatr Oncol. 2017 Sep;8(5):368-373. doi: 10.1016/j.jgo.2017.05.006.
10
Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.前列腺癌患者生化复发低、中、高风险患者的放疗联合激素治疗(RT-HT):前景与治疗获益分析
Neoplasma. 2007;54(1):7-15.

引用本文的文献

1
Application of mobile internet management in the continuing care of patients after radical prostatectomy.移动互联网管理在前列腺癌根治术后患者延续性护理中的应用
Sci Rep. 2024 Dec 28;14(1):31520. doi: 10.1038/s41598-024-83303-9.